Allen Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.48M | Sell |
12,280
-2,400
| -16% | -$277K | 0.02% | 139 |
|
|
2025
Q4 | $1.55M | Buy |
14,680
+7,875
| +116% | +$739K | 0.02% | 136 |
|
|
2025
Q3 | $571K | Sell |
6,805
-6,000
| -47% | -$494K | 0.01% | 157 |
|
|
2025
Q2 | $1.01M | Sell |
12,805
-96
| -0.7% | -$7.63K | 0.01% | 135 |
|
|
2025
Q1 | $1.16M | Hold |
12,901
| – | – | 0.01% | 134 |
|
|
2024
Q4 | $1.28M | Sell |
12,901
-23,523
| -65% | -$2.43M | 0.01% | 130 |
|
|
2024
Q3 | $4.14M | Hold |
36,424
| – | – | 0.05% | 93 |
|
|
2024
Q2 | $4.51M | Hold |
36,424
| – | – | 0.05% | 96 |
|
|
2024
Q1 | $4.81M | Hold |
36,424
| – | – | 0.06% | 86 |
|
|
2023
Q4 | $3.97M | Buy |
36,424
+6
| +0% | +$623 | 0.05% | 92 |
|
|
2023
Q3 | $3.75M | Buy |
36,418
+80
| +0.2% | +$8.62K | 0.05% | 87 |
|
|
2023
Q2 | $4.19M | Hold |
36,338
| – | – | 0.06% | 86 |
|
|
2023
Q1 | $3.87M | Hold |
36,338
| – | – | 0.06% | 80 |
|
|
2022
Q4 | $4.03M | Hold |
36,338
| – | – | 0.06% | 79 |
|
|
2022
Q3 | $3.13M | Hold |
36,338
| – | – | 0.05% | 87 |
|
|
2022
Q2 | $3.31M | Sell |
36,338
-2,700
| -7% | -$239K | 0.05% | 86 |
|
|
2022
Q1 | $3.2M | Hold |
39,038
| – | – | 0.04% | 94 |
|
|
2021
Q4 | $2.99M | Buy |
39,038
+23,068
| +144% | +$1.84M | 0.04% | 100 |
|
|
2021
Q3 | $1.2M | Buy |
15,970
+9,000
| +129% | +$684K | 0.02% | 113 |
|
|
2021
Q2 | $542K | Sell |
6,970
-5,097
| -42% | -$379K | 0.01% | 132 |
|
|
2021
Q1 | $888K | Sell |
12,067
-1,141
| -9% | -$84.2K | 0.01% | 119 |
|
|
2020
Q4 | $1.03M | Sell |
13,208
-712
| -5% | -$54.5K | 0.02% | 107 |
|
|
2020
Q3 | $1.1M | Buy |
13,920
+2,919
| +27% | +$229K | 0.02% | 99 |
|
|
2020
Q2 | $812K | Sell |
11,001
-29
| -0.3% | -$2.18K | 0.02% | 108 |
|
|
2020
Q1 | $810K | Buy |
11,030
+952
| +9% | +$74.8K | 0.02% | 101 |
|
|
2019
Q4 | $875K | Sell |
10,078
-1,932
| -16% | -$159K | 0.02% | 110 |
|
|
2019
Q3 | $965K | Buy |
12,010
+140
| +1% | +$11.2K | 0.03% | 109 |
|
|
2019
Q2 | $950K | Buy |
11,870
+151
| +1% | +$11.6K | 0.03% | 112 |
|
|
2019
Q1 | $930K | Buy |
11,719
+7,701
| +192% | +$576K | 0.03% | 106 |
|
|
2018
Q4 | $293K | Buy |
4,018
+409
| +11% | +$28.9K | 0.01% | 142 |
|
|
2018
Q3 | $244K | Hold |
3,609
| – | – | 0.01% | 175 |
|
|
2018
Q2 | $209K | Buy |
+3,609
| New | +$204K | 0.01% | 174 |
|
|
2018
Q1 | – | Sell |
-4,228
| Closed | -$227K | – | 178 |
|
|
2017
Q4 | $227K | Sell |
4,228
-657
| -13% | -$36.4K | 0.01% | 164 |
|
|
2017
Q3 | $298K | Buy |
4,885
+1,586
| +48% | +$96.2K | 0.01% | 188 |
|
|
2017
Q2 | $202K | Buy |
+3,299
| New | +$201K | 0.01% | 212 |
|
Other funds holding MRK
VCM
VPM
Allen Investment Management's MRK Position: Q1 2026 in Review
Allen Investment Management reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $277K and leaving 12,280 shares worth $1.48M. The position accounts for 0.02% of the portfolio, ranked #139.
Allen Investment Management first reported a position in MRK in Q2 2017 and has held it in 35 quarters since. The position peaked at $4.81M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Allen Investment Management held 12,280 shares of Merck worth $1.48M as of Q1 2026.
- Allen Investment Management sold 2,400 Merck shares in Q1 2026, an estimated $277K.
- Merck made up 0.02% of Allen Investment Management's portfolio in Q1 2026, its #139 holding.
- Allen Investment Management first reported a position in Merck in Q2 2017 and has held it in 35 quarters since.
- Allen Investment Management's Merck position peaked at $4.81M in Q1 2024.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Allen Investment Management's 13F filing for Q1 2026, filed 7 May 2026.